Learning Objectives:
1. Understand current challenges of type 1 diabetes management.
2. Review recent new onset type 1 diabetes trials, and appreciate successes and limitations.
3. Anticipate where new efforts may be fruitful in preserving beta cell mass.
Session date:
12/13/2021 - 12:00pm to 1:00pm CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Stephen Gitelman, M.D.